NCT01118676 2026-04-14
Cilengitide Together With Radiochemotherapy in Patients With Locally Advanced Non Small Cell Lung Cancer
Institut Claudius Regaud
Phase 1 Completed
Clinical Trials
35 trialsNCT07479628 2026-03-18
Neoadjuvant Adebrelimab Plus CRT for Locally Advanced Thymic Carcinoma
Shanghai Chest Hospital
Phase 2 Not yet recruiting
NCT04913311 2026-02-19
Predictive Biomarkers for Pneumonitis After Chemoradiotherapy and Immunotherapy in Patients With Non-small Cell Lung Cancer
M.D. Anderson Cancer Center
Recruiting
NCT06810609 2026-01-27
InDuRanS
University Hospital, Bonn
Phase 2 Recruiting
NCT07264647 2025-12-04
Neoadjuvant Chemo-immunotherapy for Stage III PD-L1 Positive Non-Small Cell Lung Cancer (NSCLC)
Fondazione Ricerca Traslazionale
Phase 2 Recruiting
NCT04305613 2025-10-02
CLARITY
Abramson Cancer Center at Penn Medicine
Active not recruiting
NCT07200154 2025-09-30
Adebrelimab Plus Chemoradiotherapy Followed by Adebrelimab Maintenance in Limited-Stage SCLC
Peking University Cancer Hospital & Institute
Phase 2 Not yet recruiting
NCT06448910 2025-09-24
Cadonilimab(AK104) Plus Concurrent Chemoradiotherapy in Patients With Locally Advanced, Unresectable, Stage III NSCLC
Fudan University
Phase 2 Active not recruiting
NCT02788461 2025-09-18
PET-BOOST
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Phase NA Active not recruiting
NCT06998719 2025-05-31
ACCESS
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase 2 Not yet recruiting
NCT06944470 2025-04-25
JS207 Combined With Chemotherapy in Subjects With Stage II-III NSCLC
Shanghai Junshi Bioscience Co., Ltd.
Phase 2 Not yet recruiting
NCT06908070 2025-04-03
CROWD
Amsterdam UMC, location VUmc
Phase 4 Recruiting
NCT06768307 2025-01-10
Assessment of Adebelizumab Combined with Chemotherapy in Concurrent Radiotherapy Versus Sequential Radiotherapy As First-Line Treatment for Extensive-Stage Small Cell Lung Cancer
Peking University Cancer Hospital & Institute
Phase 2 Not yet recruiting
NCT04866017 2024-10-31
A Study to Compare Ociperlimab Plus Tislelizumab Versus Durvalumab Following Concurrent Chemoradiotherapy (cCRT) in Participants With Stage III Unresectable Non-Small Cell Lung Cancer
BeiGene
Phase 3 Terminated
NCT04952597 2024-10-26
Study of Ociperlimab Plus Tislelizumab Plus Chemoradiotherapy in Participants With Untreated Limited-Stage Small Cell Lung Cancer
BeiGene
Phase 2 Completed
NCT04183218 2024-08-23
Characterizing Chemo-Radiotherapy Treatment-Related Cardiac Changes
Mayo Clinic
Completed
NCT02421718 2024-02-28
Standard Follow-up Program (SFP) for Lung Cancer Patients Treated With Radiotherapy or Chemoradiation
University Medical Center Groningen
Recruiting
NCT05258448 2023-12-06
COLA
Odense University Hospital
Recruiting
NCT05904015 2023-06-15
The Study of Envafolimab Combined With Concurrent Chemoradiotherapy In LS-SCLC
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase 2 Not yet recruiting
NCT02805530 2023-05-06
Radical Treatment of Synchronous Oligometastatic Non-Small Cell Lung Carcinoma
Instituto Nacional de Cancerologia de Mexico
Phase NA Completed
NCT05481775 2022-11-21
Evaluating Efficacy and Safety of Anlotinib Combined With Concurrent Chemoradiotherapy Followed by Consolidation Immunotherapy for Locally Advanced Non-small Cell Lung Cancer
Sun Yat-sen University
Phase 2 Withdrawn
NCT04958993 2022-02-25
A Trial of Anlotinib Combined With Concurrent Chemoradiotherapy in Patients With Unresectable Stage III Non-small Cell Lung Cancer
Shandong Cancer Hospital and Institute
Phase 1/2 Terminated
NCT03663764 2021-12-10
Hypofractionated Chemoradiotherapy and Thymosin α1 in Unresectable or Recurrent Thymic Epithelial Tumor
Sun Yat-sen University
Phase 2 Unknown
NCT04882033 2021-05-11
Concurrent Chemoradiotherapy Combination With Anlotinib for Limited-stage Small Cell Lung Cancer
Tianjin Medical University Cancer Institute and Hospital
Phase 1 Unknown
NCT01066234 2021-03-22
Adjuvant CCRT vs CT in Minimal N2 NSCLC
Samsung Medical Center
Phase 2 Completed
NCT03598517 2020-08-25
High Dose Radiation Therapy With Concurrent Chemotherapy in Locally Advanced Non-small Cell Lung Cancer
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Phase NA Unknown
NCT03745222 2020-07-15
RATIONALE001
Celgene
Phase 3 Terminated
NCT02076477 2020-03-17
OITROLC
Sichuan Cancer Hospital and Research Institute
Phase 3 Unknown
NCT02745691 2019-12-13
Psychometric Properties of the EORTC QLQ-LC29
University Hospital Regensburg
Completed
NCT03672136 2018-09-14
Concurrent Chemoradiotherapy Combination With Anlotinib for Unresectable Stage III NSCLC Patients
Shandong Cancer Hospital and Institute
Phase 2 Unknown
NCT00431613 2015-05-29
Study of Docetaxel/Gemcitabine Followed by Chemo-radiotherapy (Chemo-RT), With or Without Consolidation Chemotherapy, in IIIA/IIIB Non Small Cell Lung Cancer (NSCLC)
Hellenic Oncology Research Group
Phase 2 Terminated
NCT02215356 2014-08-13
Icotinib With Concurrent Radiotherapy Versus Chemotherapy With Concurrent Radiotherapy in Non-small Cell Lung Cancer
Betta Pharmaceuticals Co., Ltd.
Phase 2 Unknown
NCT01494558 2011-12-19
Study of Etoposide, Cisplatin, and Radiotherapy Versus Paclitaxel, Carboplatin and Radiotherapy to Treat Non-Small Cell Lung Cancer
ChineseAMS
Phase 2/3 Completed
NCT00686322 2011-09-15
Concurrent Chemoradiotherapy (CCRT) With Paclitaxel Plus Cisplatin in LA Non-small-cell Lung Cancer (NSCLC)
Taipei Veterans General Hospital, Taiwan
Phase 4 Completed
NCT00490659 2007-06-25
Trial of Perioperative Chemotherapy (Gemcitabine and Cisplatin) and Adjuvant Chemoradiotherapy (With Weekly Low Dose Gemcitabine) in Patients With Lung Cancer With Positive Nodes
Eli Lilly and Company
Phase 2 Completed